Find comprehensive information on erectile dysfunction (ED), also known as impotence. This resource covers healthcare aspects of ED, including clinical documentation, medical coding, ICD-10 codes for erectile dysfunction, diagnosis of impotence, treatment options for ED, and managing erectile dysfunction in clinical settings. Learn about the latest guidelines for documenting ED and relevant medical billing codes.
Also known as
Disorders of male genital organs
Covers various male genital disorders, including erectile dysfunction.
Sexual dysfunction, not caused by organic disorder or disease
Includes non-organic sexual dysfunctions like psychologically-based ED.
Pain, not elsewhere classified
May be relevant if pain is associated with erectile dysfunction.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the erectile dysfunction organic?
Yes
Due to a drug or other medical condition?
No
Is it psychogenic?
When to use each related code
Description |
---|
Persistent inability to achieve or maintain an erection. |
Reduced libido or sexual desire in men. |
Premature ejaculation, impacting sexual satisfaction. |
Coding ED without specifying organic vs. psychogenic cause can lead to inaccurate severity and treatment reflection.
Failing to code related conditions like diabetes, hypertension, or depression can impact risk adjustment and care.
Incorrect coding based on age can affect quality reporting and statistical analysis for ED prevalence.
Q: What are the most effective evidence-based treatment strategies for managing erectile dysfunction in patients with comorbidities like diabetes and hypertension?
A: Managing erectile dysfunction (ED) in patients with comorbidities like diabetes and hypertension requires a multifaceted approach. First-line treatments often include PDE5 inhibitors (e.g., sildenafil, tadalafil) but their efficacy can be influenced by these comorbidities. Consider implementing lifestyle modifications such as weight loss, improved diet, and increased physical activity, as these can positively impact both ED and overall cardiovascular health. For patients unresponsive to PDE5 inhibitors, explore second-line options like vacuum erection devices, intracavernosal injections, or penile implants. It's crucial to thoroughly assess the patient's medication regimen, as some antihypertensives can exacerbate ED. Furthermore, optimizing glycemic control in diabetic patients is essential. Explore how combination therapies and individualized treatment plans can improve outcomes for complex cases. Always prioritize shared decision-making and open communication with the patient to ensure adherence and satisfaction with the chosen treatment strategy.
Q: How can clinicians effectively differentiate between organic and psychogenic erectile dysfunction during patient evaluation and what specific diagnostic tests are recommended?
A: Distinguishing between organic and psychogenic erectile dysfunction (ED) necessitates a comprehensive patient evaluation including a thorough medical and sexual history. Questions should explore the onset and duration of ED, presence of morning erections, and any contributing psychological factors like stress, anxiety, or relationship issues. Nocturnal penile tumescence (NPT) testing can help differentiate, as the presence of normal nocturnal erections suggests a psychogenic component. However, the absence of NPT doesn't definitively confirm organic ED. Further diagnostic tests for organic ED may include vascular studies (e.g., duplex ultrasound), hormonal profiles (e.g., testosterone levels), and neurological assessments depending on the suspected etiology. Consider implementing validated questionnaires like the International Index of Erectile Function (IIEF) for a more standardized assessment of ED severity. Learn more about the interplay between organic and psychogenic factors, as many cases involve a combination of both.
Patient presents with complaints consistent with erectile dysfunction (ED), also known as impotence. The patient reports difficulty achieving and maintaining an erection sufficient for satisfactory sexual intercourse. Onset of symptoms was [timeframe] and is [gradual/sudden]. The patient reports [frequency] of successful intercourse attempts. Contributing factors explored included lifestyle factors such as diet, exercise, and smoking history, as well as psychological factors such as stress, anxiety, and relationship issues. Medical history was reviewed, including current medications, history of cardiovascular disease, diabetes, hypertension, and neurological conditions. Physical examination findings were [relevant findings or "unremarkable"]. Assessment includes erectile dysfunction (ICD-10-CM code N52.9). Differential diagnosis considered vascular insufficiency, neurogenic ED, psychogenic ED, and medication-induced ED. Treatment plan includes [pharmacological interventions such as PDE5 inhibitors e.g., sildenafil, tadalafil, vardenafil] and/or [non-pharmacological interventions such as lifestyle modifications, counseling, vacuum erection devices, penile injections, or surgical options if appropriate]. Patient education provided on the causes of erectile dysfunction, treatment options, and potential side effects. Follow-up scheduled in [timeframe] to assess treatment efficacy and adjust plan as needed. Patient advised to contact the office with any concerns or changes in symptoms. This documentation supports medical necessity for evaluation and management of erectile dysfunction.